Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes

Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes

Abstract Aims/Introduction To assess whether the sodium–glucose cotransporter 2 inhibitor, henagliflozin, improves cognitive impairment in patients with type 2 diabetes. Materials and Methods We carried out a prospective study on 290 patients with type 2 diabetes and cognitive impairment. Montreal C...

Full description

Saved in:
Bibliographic Details
Main Authors: Shujun Zhang, Fen Wang, Lei Xie, Jialu Xu, Xiaoqing Song, Jing Tao, Juan Chen, Delin Ma, Xuefeng Yu, Xiaoli Shi, Yan Yang
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:Journal of Diabetes Investigation
Subjects:
Cognitive impairment
Henagliflozin
Type 2 diabetes
Online Access:https://doi.org/10.1111/jdi.14306
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items